Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EBIT Margin

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Margin(%) 32.5148.6039.0830.429.92

What is the latest EBIT Margin ratio of NATCO PHARMA ?

The latest EBIT Margin ratio of NATCO PHARMA is 32.51 based on Mar2026 Consolidated results.
Year EBIT Margin
Mar202632.51
Mar202548.60
Mar202439.08
Mar202330.42
Mar20229.92

How is EBIT Margin of NATCO PHARMA Trending?

Years EBIT Margin % Change
Mar2026 32.51
-33.11
Mar2025 48.6
24.36
Mar2024 39.08
28.47
Mar2023 30.42
206.65
Mar2022 9.92 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Margin ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,018.4 Cr -1.3% -8.6% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.3%

-8.6%

-4.2%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses